Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Abstract Alzheimer's disease (AD) is one of the chief neurological difficulties in the aged population, identified through dementia, memory disturbance, and reduced cognitive abilities. β‐amyloid (Aβ) plaques aggregations, generation of reactive oxygen species, and mitochondrial dysfunction are...
Main Authors: | Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, Fariborz Bahrehmand, Sajad Fakhri, Somayeh Kakehbaraei, Seyran Kakebaraei |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-IET
2023-05-01
|
Series: | IET Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1049/nbt2.12127 |
Similar Items
-
Curcuminoids and resveratrol as anti-Alzheimer agents
by: Oliver B. Villaflores, et al.
Published: (2012-12-01) -
Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer’s Disease
by: Tom L. Broderick, et al.
Published: (2020-10-01) -
Research Progress on the Regulation of Resveratrol on Alzheimer’s Disease
by: WU Liangwen, ZHANG Hu, WU Tong, CHEN Ning
Published: (2023-02-01) -
Neuroprotective effects of Resveratrol in Alzheimer Disease Pathology
by: Shraddha D Rege, et al.
Published: (2014-09-01) -
History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer’s disease
by: Mohd Sajad, et al.
Published: (2022-06-01)